UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients

Clinical trial NCT03164447 · UNKNOWN

Trial details

NCT number: NCT03164447
Sponsor: United BioPharma
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2023-12-01
Primary completion: 2024-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.